KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Short term Debt (2016 - 2025)

Historic Short term Debt for Eli Lilly (LLY) over the last 17 years, with Q4 2025 value amounting to $1.6 billion.

  • Eli Lilly's Short term Debt fell 6804.77% to $1.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 billion, marking a year-over-year decrease of 6804.77%. This contributed to the annual value of $1.6 billion for FY2025, which is 6804.77% down from last year.
  • Eli Lilly's Short term Debt amounted to $1.6 billion in Q4 2025, which was down 6804.77% from $1.6 billion recorded in Q3 2025.
  • In the past 5 years, Eli Lilly's Short term Debt ranged from a high of $6.9 billion in Q4 2023 and a low of $3.1 million during Q1 2023
  • In the last 5 years, Eli Lilly's Short term Debt had a median value of $1.7 billion in 2022 and averaged $2.4 billion.
  • As far as peak fluctuations go, Eli Lilly's Short term Debt tumbled by 9984.91% in 2021, and later soared by 5317419.35% in 2024.
  • Over the past 5 years, Eli Lilly's Short term Debt (Quarter) stood at $1.5 billion in 2021, then fell by 2.42% to $1.5 billion in 2022, then surged by 359.96% to $6.9 billion in 2023, then fell by 25.89% to $5.1 billion in 2024, then tumbled by 68.05% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q4 2025, $1.6 billion for Q3 2025, and $5.7 billion during Q2 2025.